This just proves that their approach is workable for almost anything.
Think about it. Mers mechanism is not understood yet.
Why does it effect the lungs and kidneys only. If the pre-clinical trial is so successful than why not fast track
it. 43% die from mers anyway.
Cramer said to sell biotechs. Its because of the obamacare failures. Biotechs went up on the belief that obamacare was to expand the use of drugs. Ino has had a great run and people are just taking money off the table. I don't blame them but once the news comes that all is well with obamacare and then Ino comes out with partner or other good news this baby will skyrocket.